Ultrasound-mediated gene delivery to achieve therapeutic correction of hemophilia a

Ended Project Grant Awarded Last action

Award ID
R01HL151077
Recipient
Awarding agency
Obligated
$3,182,957

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Place of performance
Seattle, WA 98101, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$572
Amendment $0
Amendment $774,217
Amendment $77,425
Amendment $696,792
Amendment $774,401
Original award $860,694

Subawards

Subrecipient Amount Awarded
University Of Washington Dr. Zhang’s group has extensive experiences on image-guided interventional procedures for both patients and animals for more than 10 years. His group… $302,457
Fred Hutchinson Cancer Center n order to facilitate the translation of this protocol into human applications, we propose to further optimize FVIII gene transfer vectors, US-mediated gene… $280,676
Sonic Concepts, Inc. Sonic Concepts will provide engineering and technical support in the areas of HIFU transducers and transmitter electronics. Sonic Concepts will help to define… $99,148
University Of North Carolina At Chapel Hill Under fluoroscopic guidance, hemophilia A dogs will receive an infusion of plasmid based gene therapy into their liver. A microbubble solution may also be given… $497,508

Quick answers

Who received award R01HL151077?

R01HL151077 was awarded to Seattle Children's Hospital by National Heart Lung and Blood Institute (National Institutes of Health) on March 15, 2020.

How much is award R01HL151077 worth?

$3,182,957 has been obligated on R01HL151077.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login